Dupilumab, a biological drug for treating asthma, atopic dermatitis and CRSwNP, suppresses IL-4 and IL-13 signaling, on which the expression of ALOX-15 is strictly dependent (28). This evidence concerns the gene ALOX15 and chronic rhinosinusitis with nasal polyps.